Billings Clinic
Especially For:

Clinical Trials

Title   GI: Metastatic First Line Colorectal
Description   MAVERICC: A Randomized Phase II Study of Bevacizumab/mFOLFOX6 vs. Bevacizumab/FOLFIRI With Biomarker Stratification In Patients With Previously Untreated metastatic Colorectal Cancer
IRB Number   ML 25710
Category   Gastrointestinal
Inclusion/Notes   1. Histologically or cytologically confirmed CRC with at least one measurable metastatic lesion by RECIST 1.1
2. Archival tumor tissue sample must be available.

Please contact Tricia Montgomery, RN for additional inclusion/exclusion criteria.
Status   Open
Start Date   08/25/2011
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Tricia Montgomery
Contact Email   tmontgomery@billingsclinic.org
Phone   (406) 435-7483
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.